Moderna said its combination vaccine targeting Covid and the flu was more effective than existing standalone shots for those viruses in a late-stage trial.
Moderna plans to file for regulatory approval for its combination jab this summer in the U.S. and hopes it can enter the market in 2025, said the company's CEO Stephane Bancel.that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial.Moderna plans to file for regulatory approval for its combination jab this summer in the U.S.
Bancel added that combination shots could reduce the burden of respiratory viruses on pharmacists and the broader U.S. health-care system, which has been grappling with a labor shortage that has many workers stretched thin.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCNewYork - 🏆 270. / 63 Read more »
Source: CNBC - 🏆 12. / 72 Read more »